MedPath

Effect of 4 weeks of egoscue exercises with conventional physiotherapy on pain,disability abd lumbar hyperlordosis in post natal females with pelvic girdle pain.

Phase 2
Recruiting
Conditions
Pregnancy, childbirth and the puerperium,
Registration Number
CTRI/2024/01/061232
Lead Sponsor
DVVPFs College of physiotherapy
Brief Summary

The study is to identify the effectiveness of Egoscue exercises over Conventional physiotherapy along with stretching on various outcome parameters such as pain, disability, and lumbar lordosis in postnatal females with pelvic girdle pain all included patients will be divided into two groups. group A will receive egoscue exercises protocol with conventional physiotherapy group B will receive conventional physiotherapy along with both groups will receive common stretching exercises. ODI, anterior pelvic tilt, and lumbar lordosis percentage are primary outcome measures with the new york postural rating scale and an active straight leg raise test will be assessed at baseline and after 4 weeks of intervention. Anterior pelvic tilting with the help of a pelvic inclinometer, the percentage of lumbar lordosis will be measured by flexi curve Oswestry disability index, New York posture assessment chart, and ASLR will be measured. In both experimental and conventional group treatment protocols total duration of the session would be 35 to 40 minutes.   Data will be collected by using a structure proforma. Data will be entered in an MS excel sheet and will be analyzed by using SPSS 24.0 version IBM USA. Qualitative data will be expressed in terms of proportions Quantitative data will be expressed in terms of Mean and Standard deviation. Association between two qualitative variables will be seen by using Chi-square/ Fischer’s exact test.

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Female
Target Recruitment
115
Inclusion Criteria
  • Primiparous women between the ages 18 and 38 years. -Subjects will be eligible for the study after suture removal within 12 weeks following the caesarean section delivery. -Anterior pelvic tilting more than 13- 15 degree -Pain experienced distal to L5 and pain in the pelvic girdle region between the posterior iliac crest and the gluteal fold, with or without radiation in the posterior thigh and calf, and with and without pain in the symphysis.
  • Pain onset during pregnancy or within 12 weeks from delivery. -Subjects willing to participate -Subject should have fulfillment of the diagnostic criteria based on the following tests: ASLR test, P4 test and symphysis pubis palpation test. (Score of at least 2) -Positive pelvic pain provocation test must reproduce a familiar pain in the woman, with regard to location and quality.
Exclusion Criteria
  • Subjects not willing or unable to provide informed consent.
  • Women with a history of systemic locomotor system disease.
  • Previous surgery of the spine, pelvis, or femur, back pain indicating radiculopathy.
  • Subjects with other pain conditions, or contraindications to treatment were excluded -Generalized osteoporosis.
  • Suture infection or unhealed -Gynecological problems where the woman was advised complete bed rest.
  • Treatment with stabilizing exercises or general exercises that focused on the lumbopelvic system in the 3 months prior to this.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.Degree of lumbar lordosis using index of lumbar lordosis 2.Anterior pelvic tilt using pelvic inclinometer3.Oswestry disability Index:Baseline | after 4 weeks
Secondary Outcome Measures
NameTimeMethod
New York Posture Rating Scale (NYPRS)Functional active straight leg raise test (ASLR test)

Trial Locations

Locations (1)

DVVPFs College Of physiotherapy, Ahmadnagar

🇮🇳

Ahmadnagar, MAHARASHTRA, India

DVVPFs College Of physiotherapy, Ahmadnagar
🇮🇳Ahmadnagar, MAHARASHTRA, India
Dr Shital Ghule
Principal investigator
9689568795
shitalphad900@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.